| Financial Year |
March 31 2023 |
| Monetary Funds |
220,044,851.51 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
72,395,728.69 |
| Advances to Suppliers |
16,689,716.68 |
| Other Receivables |
5,184,853.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
206,460,224.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,859,673.43 |
| Total Current Assets |
545,635,048.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,413,896.33 |
| Investment Properties |
-- |
| Fixed Assetes |
666,945,821.58 |
| Under-construction Projects |
123,592,129.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,762,655.07 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,526,806.37 |
| Deferred Income Tax Assets |
14,362,431.31 |
| Other Non-Current Assets |
58,646,384.05 |
| Sub-Total of Non-Current Assets |
988,394,728.65 |
| Total Assets |
1,534,029,777.17 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
154,720,626.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
13,301,389.76 |
| Taxes Payable |
22,277,667.16 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
98,514,986.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,822,552.68 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
307,173,420.31 |
| Long-term Loans |
112,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
23,207,772.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
136,021,101.16 |
| Total Liabilities |
443,194,521.47 |
| Paid-In Capital(Or Share Stock) |
86,642,436.00 |
| Capital Surplus |
564,604,498.09 |
| Surplus Reserve |
40,027,145.84 |
| LESS:Treasury Stock |
47,471,938.00 |
| Undistributed Profits |
447,391,902.36 |
| Minority Stockholder's Interest |
-358,788.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,091,194,044.29 |
| Owner's Equity（Stockholder's Equity） |
1,090,835,255.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,534,029,777.17 |
